Skip to main navigation Skip to search Skip to main content

Concordance of multispectral immunofluorescence (mIF) with programmed death ligand 1 (PD-L1) and stromal tumor infiltrating lymphocyte (sTILs) clinical assays in early-stage breast cancer (BC).

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology
StatePublished - May 25 2020

Disciplines

  • Oncology

Cite this